Maternal and Infant Health Section (Dzakpasu, Nelson), Public Health Agency of Canada, Ottawa, Ont.; McMaster Midwifery Research Centre, and Department of Obstetrics and Gynecology (Darling), McMaster University, Hamilton, Ont.; Department of Anesthesia and Pain Medicine, and Faculty of Medicine (Edwards), University of Ottawa, Ottawa, Ont.; Newfoundland and Labrador Health Services (Murphy), St. John's, NL; Department of Obstetrics and Gynaecology (Scott, Van den Hof), IWK Health Centre; Dalhousie University (Scott, Van den Hof), Halifax, NS; Department of Obstetrics and Gynaecology (Ray), St. Michael's Hospital; Departments of Medicine, Health Policy Management and Evaluation (Ray), University of Toronto, Ont.
CMAJ. 2024 Jul 28;196(26):E897-E904. doi: 10.1503/cmaj.231547.
Hypertensive disorders of pregnancy (HDP) are a leading cause of severe maternal morbidity (SMM). We sought to explore trends in HDP and related morbidity outcomes in Canada.
In this retrospective population-based study, we used hospital discharge data from Canada, excluding Quebec, to identify females who had an HDP diagnosis during a birth admission between 2012 and 2021. We analyzed temporal and geographical trends in HDP, as well as temporal trends in adverse outcomes associated with HDP.
Among 2 804 473 hospital admissions for birth between 2012 and 2021, the rate of any HDP increased from 6.1% to 8.5%, including pre-existing hypertension (0.6% to 0.9%), gestational hypertension (3.9% to 5.1%), and preeclampsia (1.6% to 2.6%). For 2017-2021 combined, relative to Ontario (6.9%), HDP were significantly more prevalent in nearly all other Canadian regions. For example, in Newfoundland and Labrador, the rate was 10.7% (unadjusted rate ratio 1.56, 95% confidence interval 1.49-1.63). Among females with any HDP, rates of cesarean delivery rose from 42.0% in 2012 to 44.3% in 2021, as did acute renal failure (0.4% to 0.6%), while rates of early preterm delivery, intrauterine fetal death, maternal hospital length of stay (≥ 7 d), admission to the maternal intensive care unit, severe hemorrhage, and SMM trended downward.
The rate of HDP has risen across Canada, with a concomitant decline in some HDP-associated morbidities. Ongoing surveillance of HDP is needed to assess the factors associated with temporal trends, including the effectiveness of evolving HDP prevention and management efforts.
妊娠高血压疾病(HDP)是导致严重产妇发病率(SMM)的主要原因。我们试图探索加拿大 HDP 及相关发病率结局的趋势。
在这项回顾性基于人群的研究中,我们使用加拿大除魁北克省以外的医院出院数据,确定在 2012 年至 2021 年期间分娩住院期间有 HDP 诊断的女性。我们分析了 HDP 的时间和地理趋势,以及与 HDP 相关的不良结局的时间趋势。
在 2012 年至 2021 年期间的 2804473 例分娩住院中,任何 HDP 的发生率从 6.1%增加到 8.5%,包括孕前高血压(0.6%至 0.9%)、妊娠期高血压(3.9%至 5.1%)和子痫前期(1.6%至 2.6%)。对于 2017 年至 2021 年的综合情况,与安大略省(6.9%)相比,HDP 在加拿大几乎所有其他地区都更为普遍。例如,在纽芬兰和拉布拉多,这一比例为 10.7%(未调整的率比为 1.56,95%置信区间为 1.49-1.63)。在任何 HDP 的女性中,剖宫产率从 2012 年的 42.0%上升到 2021 年的 44.3%,急性肾衰竭(0.4%至 0.6%)也是如此,而早产、宫内胎儿死亡、产妇住院时间(≥7 天)、产妇重症监护病房入院、严重出血和 SMM 的发生率呈下降趋势。
加拿大各地的 HDP 发生率都有所上升,同时一些与 HDP 相关的发病率也有所下降。需要对 HDP 进行持续监测,以评估与时间趋势相关的因素,包括不断发展的 HDP 预防和管理工作的有效性。